Pillstats
Rx only · Solution/ Drops · Ophthalmic

Moxifloxacin

Moxifloxacin Hydrochloride

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)139462
US makers12 labelers
Packages15
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.524$1.05$1.57$2.10Dec 2025Apr 2026Jul 2026
$1.572
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
12
Active US suppliers
27%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

26K52K78K104K2025 Q12025 Q22025 Q32025 Q42026 Q1
72K
Rx · 2026 Q1
223K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown2SUPPLYING
Redpharm Drugunknown2SUPPLYING
Direct_Rxunknown2SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Apotex Corp.unknown1SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Lifestar Pharma LLCunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Proficient Rx LPunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 14, 2022
    RECALLRecall (Class II): Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, In…

    Failed Impurities/Degradation Specifications — Recalling firm: Aurobindo Pharma USA Inc. — USA Nationwide

  • Dec 2, 2019
    RECALLRecall (Class III): Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed …

    Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution. — Recalling firm: AuroMedics Pharma LLC — Nationwide in the U.S.

  • Feb 26, 2019
    RECALLRecall (Class III): Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 …

    Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide in the USA and Puerto Rico.

  • Feb 1, 2019
    RECALLRecall (Class III): Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.…

    Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed by 5 wholesalers, 6 drug chains, 4 mail order pharmacies and 1 mail order pharmacy/supermarket …

  • Jul 26, 2018
    RECALLRecall (Class III): Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimo…

    Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed throughout the United States